Levy Adam Scott
CFO and Secretary
Levy Adam Scott has filed 5 SEC Form 4 filings (21 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Feb 20, 2026.
On the most recent filing, Levy Adam Scott is listed as CFO and Secretary at Mineralys Therapeutics, Inc. Inside the rolling window, Levy Adam Scott reported no open-market purchases and 2 open-market sales totaling $5.7M in MLYS. The largest disclosed transaction in the window is a sale of 119,524 MLYS shares on Nov 11, 2025, worth $5.4M.
Companies traded
Other insiders at MLYS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Levy Adam Scott made?
Levy Adam Scott has filed 5 SEC Form 4 filings (21 transaction rows) across 1 company since 2025.
Which companies does Levy Adam Scott trade?
Levy Adam Scott has filed SEC Form 4 disclosures for 1 company, including MLYS.
When was Levy Adam Scott's most recent SEC Form 4 filing?
Levy Adam Scott's most recent SEC Form 4 filing on Tracefour is dated Feb 20, 2026.
What is Levy Adam Scott's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Levy Adam Scott is listed as CFO and Secretary.
What is Levy Adam Scott's total buy and sell value in the current window?
Inside the rolling retention window, Levy Adam Scott bought $0 and sold $5.7M based on SEC Form 4 filings.
What was Levy Adam Scott's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 119,524 MLYS shares on 2025-11-11, worth $5.4M, per SEC Form 4 filings.